GALT vs MSFT: Which Stock is Better?
Side-by-side comparison of Galectin Therapeutics Inc and Microsoft Corp in 2026
GALT
Galectin Therapeutics Inc
$2.45
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | GALT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $148.77M | N/A | GALT |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze GALT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GALT or MSFT a better investment?
Comparing GALT and MSFT: Galectin Therapeutics Inc has a market cap of $148.77M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GALT and MSFT?
GALT (Galectin Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GALT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GALT or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for GALT.
Which company is more profitable: GALT or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for GALT.
Which is the larger company: GALT or MSFT?
Galectin Therapeutics Inc (GALT) is larger with a market cap of $148.77M compared to N/A for MSFT.
Should I buy GALT or MSFT in 2026?
Both GALT and MSFT have investment merit. GALT trades at $2.45 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GALT and MSFT stock?
Key differences: Market Cap ($148.77M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).